GENERAL HEMOSTASIS
Total Payments
$404,509
Transactions
190
Doctors
154
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $248.49 | 7 | 5 |
| 2018 | $404,261 | 183 | 149 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $370,625 | 17 | 91.6% |
| Consulting Fee | $15,675 | 2 | 3.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,600 | 3 | 2.4% |
| Food and Beverage | $8,432 | 165 | 2.1% |
| Travel and Lodging | $177.10 | 3 | 0.0% |
Top Doctors Receiving Payments for GENERAL HEMOSTASIS — Page 7
Ad
Manufacturing Companies
- Boston Scientific Corporation $380,335
- BOSTON SCIENTIFIC CORPORATION $24,174
Product Information
- Type Device
- Total Payments $404,509
- Total Doctors 154
- Transactions 190
About GENERAL HEMOSTASIS
GENERAL HEMOSTASIS is a device associated with $404,509 in payments to 154 healthcare providers, recorded across 190 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2018 to 2021. In 2021, $248.49 was paid across 7 transactions to 5 doctors.
The most common payment nature for GENERAL HEMOSTASIS is "Grant" ($370,625, 91.6% of total).